Adult T-cell leukemia after immunosuppressive therapy for systemic lupus erythematosus.
Shimamoto
Yoshiko
Y
First Department of Internal Medicine, Kansai Medical University, 10-15 Fumizonocho, Moriguchi, Osaka, 570-8507, Japan.
Nomura
Shosaku
S
Division of Hematology, Kishiwada City Hospital, 1001 Gakuharacho, Kishiwada, Osaka, 596-8501, Japan. shosaku-n@mbp.ocn.ne.jp.
Ishii
Kazuyoshi
K
Division of Hematology, Kishiwada City Hospital, 1001 Gakuharacho, Kishiwada, Osaka, 596-8501, Japan.
Shimizu
Michiomi
M
Division of Hematology, Kishiwada City Hospital, 1001 Gakuharacho, Kishiwada, Osaka, 596-8501, Japan.
Ozaki
Yoshio
Y
First Department of Internal Medicine, Kansai Medical University, 10-15 Fumizonocho, Moriguchi, Osaka, 570-8507, Japan.
Ito
Tomoki
T
First Department of Internal Medicine, Kansai Medical University, 10-15 Fumizonocho, Moriguchi, Osaka, 570-8507, Japan.
Urase
Fumiaki
F
Department of Hematology, Kinki University, School of Medicine, Sayama, Osaka, Japan.
Maeda
Yasuhiro
Y
Department of Hematology, Kinki University, School of Medicine, Sayama, Osaka, Japan.
Fukuhara
Shirou
S
First Department of Internal Medicine, Kansai Medical University, 10-15 Fumizonocho, Moriguchi, Osaka, 570-8507, Japan.
D005260:Female; D015368:Human T-lymphotropic virus 1; D006801:Humans; D007166:Immunosuppressive Agents / Q000009:adverse effects*; D015459:Leukemia-Lymphoma, Adult T-Cell / Q000139:chemically induced / Q000209:etiology*; D008180:Lupus Erythematosus, Systemic / Q000150:complications* / Q000188:drug therapy / Q000821:virology; D008875:Middle Aged
D007166:Immunosuppressive Agents